BIOMARKERS - SCI & TECH

News: Detecting cancer in minutes possible with just a drop of dried blood and new test, study hints

 

What's in the news?

       The screening for blood biomarkers has been suggested as a promising approach to detect cancer in its early stages.

 

Biomarkers:

       It is also known as Biological Markers, are identifiable physical, chemical, or biological characteristics present in the human body that are measurable.

       The World Health Organization (WHO) defines biomarkers as measurements reflecting interactions between biological systems and potential hazards, which can be chemical, physical, or biological in nature.

 

Features:

       It is also referred to as molecular markers and signature molecules, biomarkers play a crucial role in disease diagnosis, medication prescription, dosage determination, and drug development.

       Biomarkers encompass various biomolecules such as carbohydrates, proteins, lipids, genes, DNA, RNA, platelets, enzymes, and hormones.

 

 

Classification of Biomarkers:

Based on their source or location, biomarkers can be categorized as follows.

1. Molecular Biomarkers;

       It is measurable in biological samples like blood plasma, serum, cerebrospinal fluid, and biopsy specimens.

 

2. Radiographic Biomarkers:

       It is obtained from imaging studies such as bone mineral density assessments.

 

3. Histologic Biomarkers:

       It is reflecting biochemical or molecular alterations in cells, tissues, or fluids, used in cancer staging and grading.

 

4. Physiologic Biomarkers:

       It represents measures of body processes like blood pressure, pulse rate, and heart rate.

 

Based on their roles/functions, biomarkers can be classified as follows.

1. Susceptibility/Risk Biomarkers:

       It indicates the likelihood of developing a disease or condition.

 

2. Diagnostic Biomarkers:

       It is used for disease detection or confirmation.

 

3. Prognostic Biomarkers:

       It predicts disease progression or relapse in confirmed cases.

 

4. Monitoring Biomarkers:

       It assesses disease stage, drug exposure, or environmental agent exposure.

 

5. Predictive Biomarkers:

       It identifies individuals with a higher likelihood of strong outcomes when exposed to specific drugs, aiding treatment decisions.